Meta-Analysis of COVID-19 Metabolomics Identifies Variations in Robustness of Biomarkers

The global COVID-19 pandemic resulted in widespread harms but also rapid advances in vaccine development, diagnostic testing, and treatment. As the disease moves to endemic status, the need to identify characteristic biomarkers of the disease for diagnostics or therapeutics has lessened, but lessons...

Descripción completa

Detalles Bibliográficos
Autores principales: Onoja, Anthony, von Gerichten, Johanna, Lewis, Holly-May, Bailey, Melanie J., Skene, Debra J., Geifman, Nophar, Spick, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531504/
https://www.ncbi.nlm.nih.gov/pubmed/37762673
http://dx.doi.org/10.3390/ijms241814371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531504/
https://www.ncbi.nlm.nih.gov/pubmed/37762673
http://dx.doi.org/10.3390/ijms241814371

Ejemplares similares